Comment on: Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial

Copy For Citation

ORAL F., BİLGİN E., BÖLEK E. Ç., YARDIMCI G. K., KILIÇ L.

RHEUMATOLOGY, vol.58, no.5, pp.925, 2019 (SCI-Expanded)

• Publication Type: Article / Letter
• Volume: 58 Issue: 5
• Publication Date: 2019
• Doi Number: 10.1093/rheumatology/kez033
• Journal Name: RHEUMATOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.925
• Hacettepe University Affiliated: Yes